Clinical Trial Finds Novel Therapy Markedly Reduced Lipoprotein(a) Levels in People with Cardiovascular Disease

Researchers conducted a phase 2, randomized, placebo-controlled clinical trial of olpasiran in patients with established cardiovascular disease to evaluate its safety and tolerability and to identify an optimal dose of olpasiran.
Source: BWH News - Category: Hospital Management Source Type: news